The new Clinical and Translational Core will promote and facilitate clinical and translational studies in hypertension, kidney disorders, and related cardiovascular diseases. The main functions will be: promotion of translational studies, and establishment of synergies between basic scientists, physician scientists, and population scientist;facilitation of new studies including protocol design, IRB submission, coordination of services needed, subject recruitment, data management design;performance of clinical visits;assistance with management of data and biostatistical support;sample processing and analysis;coordination with the CTC, facilities within Tulane Hospital or MCLNO, IRB;and facilitation of education and training in clinical research. Clinical and translational studies will usually be performed within two well equipped facilities: Office of Health Research physically located in the School of Public Health and Tropical Medicine;and Clinical Trials Cooperative located within Tulane Hospital. Both facilities have clinical research laboratories with a wide range of capabilities. The former also has ultrasound capabilities, a variety of equipment for vascular studies, EKG machines, and ability to perform iothalamate glomerular filtration testing. The goal is to facilitate and foster the translation of basic insights into clinical and population studies. This core will extend the existing synergies which have been developed in the first two phases of the COBRE. All of the Core personnel are experienced in clinical investigation and are knowledgeable about the ongoing research within each of the areas involved in the existing COBRE. Therefore the core will be well suited to encourage and promote new investigators into translational studies.

Public Health Relevance

Clinical and translational research in hypertension and renal diseases is an appropriate extension of ongoing basic research at Tulane. These studies have significant opportunity to improve prevention, detection, and treatment of these widespread disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM103337-01
Application #
8463749
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$163,768
Indirect Cost
$54,952
Name
Tulane University
Department
Type
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Cedillo-Couvert, Esteban A; Ricardo, Ana C; Chen, Jinsong et al. (2018) Self-reported Medication Adherence and CKD Progression. Kidney Int Rep 3:645-651
Liu, Hongbing; Chen, Shaowei; Yao, Xiao et al. (2018) Histone deacetylases 1 and 2 regulate the transcriptional programs of nephron progenitors and renal vesicles. Development 145:
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Dobre, Mirela; Gaussoin, Sarah A; Bates, Jeffrey T et al. (2018) Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults. Clin J Am Soc Nephrol 13:596-603
Shapiro, Brian P; Ambrosius, Walter T; Blackshear, Joseph L et al. (2018) Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension 71:1064-1074
Rocco, Michael V; Sink, Kaycee M; Lovato, Laura C et al. (2018) Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis 71:352-361
Beddhu, Srinivasan; Greene, Tom; Boucher, Robert et al. (2018) Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. Lancet Diabetes Endocrinol 6:555-563
Anderson, Christopher E; Hamm, L Lee; Batuman, Gem et al. (2018) The association of angiogenic factors and chronic kidney disease. BMC Nephrol 19:117
Lightell Jr, Daniel J; Moss, Stephanie C; Woods, T Cooper (2018) Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus. Atherosclerosis 269:71-78
Dungan, Kathleen; Craven, Timothy E; Soe, Kyaw et al. (2018) Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Diabetes Obes Metab 20:629-637

Showing the most recent 10 out of 240 publications